It has been reported that XIAP is upregulated in acute and chronic leukemia [3, 4], prostate cancer [5], breast cancer [6–8], and many other cancers [9–11], thus indicating an association between XIAP overexpression and cancer development [12, 13]. Here, XIAP is linked to breast cancer.